Literature DB >> 8996008

The significance of Mycobacterium avium complex cultivation in the sputum of patients with pulmonary tuberculosis.

M D Epstein1, C P Aranda, S Bonk, B Hanna, W N Rom.   

Abstract

Mycobacterium avium-intracellulare complex (MAC) is a ubiquitous environmental microorganism whose pathogenicity ranges from innocuous colonization to disease, in immunocompetent as well as immunocompromised individuals. We sought to determine the clinical significance of MAC in sputum cultures of patients with pulmonary tuberculosis (TB). A retrospective analysis between January 1994 and March 1995 at Bellevue Hospital Center revealed both Mycobacterium tuberculosis and MAC in 35 patients (11% of all patients with TB). Of 27 patients reviewed, 52% were HIV-1 infected (median CD4 + 25 cells per microliter). Radiographic manifestations in patients with TB and MAC were similar to those seen in patients with TB alone. Both mycobacteria were cultured primarily from respiratory sources. M tuberculosis was usually cultured first or concurrent with MAC, and in nearly all cases, both species were recovered within 2 months of each other. Most patients improved clinically, bacteriologically, and radiographically with standard antituberculous therapy, except those with advanced AIDS, multidrug-resistant TB (MDR-TB), or disseminated MAC. We conclude that recovery of MAC in sputum is common in patients with pulmonary TB, regardless of HIV-1 infection, MDR-TB, or other clinical, bacteriologic, or radiographic attributes. MAC cultivation in most of these patients likely represents transient colonization, and in most cases is not clinically significant.

Entities:  

Mesh:

Year:  1997        PMID: 8996008     DOI: 10.1378/chest.111.1.142

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Nontuberculous Mycobacterial Infections of the Lung.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

2.  The significance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapy.

Authors:  David E Griffith; Julie V Philley; Barbara A Brown-Elliott; Jeana L Benwill; Sara Shepherd; Deanna York; Richard J Wallace
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

3.  Targeted delivery of amikacin into granuloma.

Authors:  Ana Montes-Worboys; Scott Brown; Doron Regev; Brendan F Bellew; Kamal A Mohammed; Ibrahim Faruqi; Parvesh Sharma; Brij Moudgil; Veena B Antony
Journal:  Am J Respir Crit Care Med       Date:  2010-08-06       Impact factor: 21.405

4.  Investigation of mycobacterial colonisation and invasion of the respiratory mucosa.

Authors:  A M Middleton; M V Chadwick; A G Nicholson; A Dewar; C Feldman; R Wilson
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

5.  Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria.

Authors:  B A Hanna; A Ebrahimzadeh; L B Elliott; M A Morgan; S M Novak; S Rusch-Gerdes; M Acio; D F Dunbar; T M Holmes; C H Rexer; C Savthyakumar; A M Vannier
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Modification of results of drug susceptibility tests by coexistence of Mycobacterium avium complex with Mycobacterium tuberculosis in a sputum sample: case report and experimental considerations.

Authors:  K Suzuki; T Kimoto; K Tsuyuguchi; H Matsumoto; A Niimi; E Tanaka; T Murayama; R Amitani
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

7.  The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.

Authors:  Mao-Shui Wang; Jun-Li Wang; Xin-Feng Wang
Journal:  BMC Pulm Med       Date:  2016-11-25       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.